VIATRIS INC. for VIATRIS INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Biosimilar Naming, Issues related to implementation of the Generic Drug User Fee Agreement, generic drug pricing Medicaid Generic Drug Rebate, Bipartisan Budget Act of 2015, H.R. 1314
Foreign entity interest: As the parent entities of Mylan Inc., Mylan NV and Mylan Holdings Limited have a general interest in the issues above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NIMISH SHAH | — |
Trade (domestic/foreign) TRD
Issues related to Trans Pacific Partnership(TPP), General trade issues
Foreign entity interest: As the parent entities of Mylan Inc., Mylan NV and Mylan Holdings Limited have a general interest in the issues above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NAWEL LILLIAN ROJKJAER | — |
| NIMISH SHAH | — |
Copyright/Patent/Trademark CPT
Patent Reform, H.R. 9 Innovation Act, S. 632 STRONG Patents Act, S. 1137, the Patent Act, S. 2019 Preserve Access to Affordable Generics Act
Foreign entity interest: As the parent entities of Mylan Inc., Mylan NV and Mylan Holdings Limited have a general interest in the issues above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NIMISH SHAH | — |
Health Issues HCR
Biosimilar Naming, Issues related to implementation of the Generic Drug User Fee Agreement, generic drug pricing Issues related to Senate HELP Innovation Initiative Drug Supply Chain Security Act implementation of pharmaceutical distribution REMs program, H.R. 2841 FAST generics Act S. 1972 Airline Access to Emergency Epinephrine Act of 2015, Anaphylaxis awareness, access to epinephrine auto injector
Foreign entity interest: As the parent entities of Mylan Inc., Mylan NV and Mylan Holdings Limited have a general interest in the issues above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NIMISH SHAH | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| MYLAN NV | United Kingdom | United Kingdom | 100.0% | — |
| MYLAN HOLDINGS LIMITED | United Kingdom | United Kingdom | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.